<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Arrojo-Romero, Manuel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Impact of Antipsychotic Treatment on Cardiometabolic Risk</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-11</style></pages><abstract><style  face="normal" font="default" size="100%">Persons with psychiatric disorders often have a myriad of comorbid medical conditions that can add to risk for premature morbidity and mortality. Important conditions that increase risk for cardiovascular disease and diabetes include overweightness and obesity, dyslipidemia, hypertension, hyperglycemia, and smoking, all often interrelated by insulin resistance.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>